Health Care & Life Sciences » Biotechnology | Acerus Pharmaceuticals Corp.

Acerus Pharmaceuticals Corp.

Acerus Pharmaceuticals Corp.
Stock Exchange Other OTC
EPS
$0.07
Market Cap
$42.96 M
Shares Outstanding
213.19 M
Public Float
-
Acerus Pharmaceuticals Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
235.24 M
Public Float
-
Acerus Pharmaceuticals Corp.
Stock Exchange Toronto Stock Exchange Prices
EPS
CAD0.11
Market Cap
CAD27.43 M
Shares Outstanding
213.12 M
Public Float
97.53 M

Profile

Address
2486 Dunwin Drive
Mississauga Ontario L5L 1J9
Canada
Employees -
Website http://www.aceruspharma.com
Updated 07/08/2019
Acerus Pharmaceuticals Corp. operates as a pharmaceutical company, which engages in the development, manufacture, production, marketing and distribution of women and men's health products. It focuses on the treatment of urology, hormone replacement therapy, and female dysfunction. Its products include Estrace, Natesto, and Tefina.

Financials

View All

Edward Gudaitis
President, Chief Executive Officer & Director
Ian Orest Ihnatowycz
Chairman